Home > Boards > US OTC > Medical - Equipment >

Curative Biotechnology Inc. (CUBT)

Add CUBT Price Alert      Hide Sticky   Hide Intro
Moderator: i_like_bb_stock, Eagle1, Stock_Barber, pepeoil, RiseandShine, trader59
Search This Board: 
Last Post: 5/7/2021 10:25:35 PM - Followers: 316 - Board type: Free - Posts Today: 0

Curative Biotechnology, Inc.



Curative Biotech is a development-stage biomedical company focusing on novel treatments for rare diseases. Curative Biotech is focused on therapies with potentially accelerated development paths as a result of either the disease, the nature of the therapeutic itself, or the stage of clinical development. At the heart of the Company is a product development engine that rests on our unique S.O.A.R. filter (Science, Opportunity, Acceleration, Rare Disease.):

Have world class science and sustainable intellectual property behind them.

Can be acquired opportunistically at favorable valuations.

Lend themselves to an accelerated approval pathway.

Address unmet medical needs for rare diseases only.


Curative Biotech (CUBT) is a development-stage biomedical company focused on novel treatments for rare diseases with eight (8) programs in three (3) different therapeutic areas. Curative Biotechnology - Novel Solutions for Unmet Medical Needs

CUBT is targeting therapies with potentially accelerated development paths as a result of either the disease, the nature of the therapeutic itself, or the stage of clinical development. At the heart of Curative Biotech is a product development engine that rests on its unique S.O.A.R. filter (Science, Opportunity, Acceleration, Rare Disease.)

Share Structure

Authorized Shares 1,100,000,000 12/4/2020
Outstanding Shares 322,800,327 12/4/2020
Restricted 99,336,588 12/4/2020
Unrestricted 223,463,739 12/4/20
Held at DTC 215,207,258 12/4/20


OTC Profile:

Official PR:
Connectyx Technologies Holdings Group announces Shareholder Update

March 06, 2020 09:30 ET | Source: Connectyx Technologies Holdings Group, Inc

BOCA RATON, FL, March 06, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group (OTC PINK: CTYX) issued a shareholder update today regarding recent corporate developments including management and Board of Director changes.

SunMed Advisors, LLC has recently acquired majority control of CTYX through the purchase of Series A Preferred stock from the two principal holders of CTYX.

Jon Pevzner, former President and Director, has resigned and Paul M. Michaels was appointed Interim CEO and Director. Mr. Michaels has business and investment experience in Japan and the U.S. with noteworthy expertise in the Life Sciences sector. He has completed transactions involving companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and Gilead Sciences.

Dr. Barry A. Ginsberg and Brandon Michaels join Mr. Michaels on the Board.

CTYX is currently in the process of updating financials to become compliant with OTCMarkets and has appointed Jonathan D. Leinwand, PA as Legal Counsel.

CTYX will continue to update shareholders on a new business plan through news releases, website updates and OTCMarkets filings as the company moves forward.

Investor Database for Future Press Releases and Industry Updates

Interested investors and shareholders are invited to be added to the corporate e-mail database for corporate press releases and periodic industry updates by sending an e-mail to: investorrelations@connectyx.com

About SunMed Advisors, LLC ( https://sunmedadvisors.com/ )

SunMed Advisors is a Life Science and Technology consulting firm that helps create maximum corporate value with strategic initiatives and a leading advisor on Pre-Commercial and Commercial-Stage licensing deals. SunMed brings value to all stages of licensing transactions, from sourcing through closing.
This part of the IBOX is being managed by RiseandShine follow me on twitter  https://twitter.com/Rise2ShineLife 

 25 year Investment Banker and Harvard Business Graduate Paul M Michaels is here!  


For the past two decades, Mr. Michaels has established lasting relationships with key business leaders and stakeholders in Japan and the U.S., particularly in the Life Sciences field. He has completed transactions that influenced companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and Gilead, to name just a few.

Paul has also provided financial leadership for almost 18 years to Inabata & Co. Ltd., one of Japan’s largest trading companies with $4.5 billion in annual sales and successfully licensed multiple drugs from Gilead (formerly Nexstar Pharmaceuticals). Throughout his tenure, he structured and closed major transactions that brought high-value products to the Japanese pharmaceutical market in addition to other corporate responsibilities that included overall evaluation of corporate asset values. Paul subsequently founded Nobelpharma, Ltd. Japan, an affiliate of Inabata & Co. Ltd., which is now one of Japan’s most profitable orphan drug companies. As President of the U.S. division and a co-Founder,he secured $35 million in initial capital and negotiated the license for the first designated orphan drug product in the company’s pipeline from Teva Pharmaceuticals.

Paul began his career as Co-Founder, Executive Vice President and Board Member of Global Capital Group, a publicly traded corporate finance firm on Wall Street where he structured, financed and advised transactions in multiple spaces utilizing a variety of financial vehicles including private placements and Initial Public Offerings.

He received his Bachelor’s degree from Tulane University and completed an HBX program from Harvard.

Paul has completed transactions that influenced companies such as Celgene Corporation.

Paul is responsible for opening up the Japanese market to US drug companies
Inabata Pharmaceuticals becomes a significant provider of pharmaceuticals and API and merges with Sumitomo Pharmaceuticals in 1983. Licensing activity begins in 1996 with Sumitomo Pharmaceuticals, through the negotiations of Investment Banker, Paul M. Michaelslicenses Ambisome and Danisome for the Asian marketplace from a U.S. Pharmaceutical company. This is the beginning of business licensing U.S. developed drugs for the Japanese market. Additionally, an Orphan drug business is created with the assistance of Paul M. Michaels with his Japanese counterparts called Nobelpharma. Co.LtdThe first licensed product, from Teva Pharmaceuticals USA, is for the treatment of Wilson's disease in Japan. This transaction was negotiated and completed by Paul Michaels.


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTYX News: Connectyx Technologies Holdings Group, Inc. reports FY results 03/09/2021 10:41:51 AM
CTYX News: Connectyx names Richard Garr CEO 02/11/2021 11:08:45 AM
#30408  Sticky Note CTYX DD Packet with hyper links! http://tinyurl.com/curativebiodd Connectyx ( Eagle1 02/06/21 05:30:12 PM
#30246  Sticky Note Here's what the pump and dump is very trader59 02/05/21 01:58:59 PM
#29144  Sticky Note This turd does not have the right to pepeoil 12/07/20 07:45:36 AM
#28773  Sticky Note DD on why this is not a game: https://investorshub.advfn.com/boards/read_ RiseandShine 10/31/20 09:31:59 PM
#33296   He said he still has 20 million shares iRobot 05/07/21 10:25:35 PM
#33295   Ahhhhhhhh Threeflight 05/07/21 08:59:18 PM
#33294   Probably before the 2010 1:50 reverse split My911Voice 05/07/21 08:57:03 PM
#33293   I got a tweet today...new blog govprs 05/07/21 08:42:31 PM
#33292   Can you screen shot your holdings please? Threeflight 05/07/21 08:24:25 PM
#33291   Wait...so you had 10% of the entire OS Threeflight 05/07/21 08:22:32 PM
#33290   Conix is just a trader. Trust me Threeflight 05/07/21 07:34:41 PM
#33289   I was here also 10 years ago Ronn moczowy 05/07/21 07:20:27 PM
#33288   How is that an excellent sign it means iRobot 05/07/21 07:11:02 PM
#33287   Conix and Prudent Capitalist were two great contributors My911Voice 05/07/21 06:47:25 PM
#33286   He is a great poster and a wonderful Threeflight 05/07/21 06:41:51 PM
#33285   There's a "Happy Hour" every Friday where PM'ing trader59 05/07/21 06:15:33 PM
#33284   A member sent me a private message his iRobot 05/07/21 06:03:42 PM
#33283   It’s not unless they decide to come out iRobot 05/07/21 04:58:01 PM
#33282   Why is it assumed that the conversion of AllinFun 05/07/21 04:56:33 PM
#33281   Won’t know that until I see if they iRobot 05/07/21 04:52:01 PM
#33280   Maybe this means we should all sell? AllinFun 05/07/21 04:50:36 PM
#33279   Where is all this PR everybody was talking iRobot 05/07/21 04:45:15 PM
#33278   Very flat day....just waiting pacman181 05/07/21 02:41:10 PM
#33275   heck yea man, just make chit up like pepeoil 05/07/21 12:04:54 PM
#33274   This is actually getting comical. Wrangler1 05/07/21 11:47:32 AM
#33273   Lol. govprs 05/07/21 10:33:14 AM
#33272   I think their other patent is for 8 pepeoil 05/07/21 10:27:03 AM
#33271   does anyone know how much this blinker fluid pepeoil 05/07/21 10:24:34 AM
#33270   yep, exciting, going to the moon with the pepeoil 05/07/21 10:14:51 AM
#33269   May 07, 2021 CUBT.12 cents CEO's Blog Eagle1 05/07/21 10:08:33 AM
#33268   Nice BLOG. I like this guy... “We have completed fat_tire 05/07/21 09:53:53 AM
#33267   yep, pimping shares instead of product, lol pepeoil 05/07/21 09:49:36 AM
#33266   New CEO blog this morning: https://curativebiotech.com/how-far-that-little-cand JBJD 05/07/21 09:42:49 AM
#33265   Yep, it’s dropped a lot from $.007! LOL fat_tire 05/07/21 09:40:59 AM
#33264   yep, exciting, this could drop another 25% . pepeoil 05/07/21 09:21:11 AM
#33263   Good morning PEPE and CUBT stockholders! Looking forward fat_tire 05/07/21 08:22:18 AM
#33262   Yep, more losses coming. The big pepeoil 05/07/21 08:03:48 AM
#33261   No product, no office, no good. pepeoil 05/07/21 07:12:49 AM
#33260   They have a powerhouse team of successful people. fat_tire 05/06/21 10:42:13 PM
#33259   Bet they are avoiding looking like a stock oxnous 05/06/21 09:10:11 PM
#33258   I’ve been raising some cash and adding today govprs 05/06/21 05:49:38 PM
#33257   And it literally takes 10 minutes a day Threeflight 05/06/21 05:06:16 PM
#33256   Yeah knowing management they will never ever release Threeflight 05/06/21 04:57:20 PM
#33255   I have quite a bit of confidence in AllinFun 05/06/21 04:50:15 PM
#33253   Well going by their "official" PR on their Vanasn 05/06/21 04:22:40 PM
#33251   Yeah it shouldn't happen but as I said Threeflight 05/06/21 04:15:31 PM
#33250   right, lots of time till then, lets see lizardlover 05/06/21 04:03:56 PM
#33249   May 31st according to last paragraph on nov iRobot 05/06/21 03:58:11 PM
#33248   LOL, how low will she go. lol pepeoil 05/06/21 03:55:57 PM
#33247   Watching with interest to see if we get mr positivity 05/06/21 03:52:27 PM
#33245   so do they convert may 15th or may lizardlover 05/06/21 03:43:25 PM
#33243   Adding more shares today sub $.12. Wrangler1 05/06/21 03:24:20 PM
#33242   Just vait until the PR's start flowing .. BEIJING BILL 05/06/21 03:23:21 PM
#33241   #4 post: CUBT has an Exclusive Patent License Wrangler1 05/06/21 03:20:48 PM
Consent Preferences